These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 12688026)
1. [Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!]. Dietrich W; Blumenstein M MMW Fortschr Med; 2003 Mar; 145(10):40-2. PubMed ID: 12688026 [No Abstract] [Full Text] [Related]
2. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension. Bakris GL; Toto RD; McCullough PA J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206 [TBL] [Abstract][Full Text] [Related]
3. [Prediction, screening and treatment of renal complications of diabetes]. Marre M; Larger E Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120 [TBL] [Abstract][Full Text] [Related]
4. [Current issues in the diagnosis and therapy of diabetic nephropathy]. de Châtel R; Mogyorósi A; Ziyadeh FN Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751 [TBL] [Abstract][Full Text] [Related]
5. [Microalbuminuria is an early marker for increased morbidity and mortality]. Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947 [TBL] [Abstract][Full Text] [Related]
6. Treating high blood pressure in Africans with type 2 diabetes. Okoro EO; Oyejola BA Ethn Dis; 2004; 14(1):160-1. PubMed ID: 15002939 [No Abstract] [Full Text] [Related]
7. [Diabetic nephropathy]. Morcos M; Zeier M; Schwenger V Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634 [No Abstract] [Full Text] [Related]
8. Controversies on the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes? Danne T; Kordonouri O J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():347-63. PubMed ID: 9642665 [TBL] [Abstract][Full Text] [Related]
9. Treating hypertension in the diabetic patient: therapeutic goals and the role of calcium channel blockers. Caldwell BV Clin Ther; 1993; 15(4):618-36; discussion 617. PubMed ID: 8221813 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Hughes DB; Britton ML Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022 [TBL] [Abstract][Full Text] [Related]
11. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?]. Luño J; Valderrábano F An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851 [No Abstract] [Full Text] [Related]
12. Clinical practice. Nephropathy in patients with type 2 diabetes. Remuzzi G; Schieppati A; Ruggenenti P N Engl J Med; 2002 Apr; 346(15):1145-51. PubMed ID: 11948275 [No Abstract] [Full Text] [Related]
13. [The kidneys and diabetes]. Rüster C; Sämann A; Wolf G Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486 [No Abstract] [Full Text] [Related]
14. [Hypertension and diabetic nephropathy, a dangerous duo]. Hausberg M; Hohage H; Kosch M Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181 [No Abstract] [Full Text] [Related]
15. Drug treatment of the hypertensive diabetic. Kendall MJ; Lewis H; Griffith M; Barnett AH J Hum Hypertens; 1988 Mar; 1(4):249-58. PubMed ID: 2906093 [No Abstract] [Full Text] [Related]
16. Effects of ACE inhibition on the course of nephropathy in type I diabetes mellitus. Meinders AE; Hes R; de Leeuw PW Neth J Med; 1992 Jun; 40(5-6):217-20. PubMed ID: 1436257 [TBL] [Abstract][Full Text] [Related]